Former NFL pro Chris Maragos wins $43.5 million medical malpractice claim

Published Date: 02 Mar 2023

The legal team said the jury's decision could make medics think twice before allowing the injured to return to the field.

Read Full News

Latest News

Ask the HF Expert: Advanced Therapies

Dr Yash Varma, a chief cardiology fellow, asks Dr Ileana Piña for her insights on when a patient with heart failure should be referred for advanced therapies.

Selpercatinib Cuts Recurrence Risk in Early RET+ NSCLC

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC.

More Women With Breast Cancer Can Skip Axillary Dissection

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

Tile-Based Radiation to Treat Large Brain Metastases?

The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions.

Will PROTEUS Change the Playbook for Radical Prostatectomy?

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

S1 Episode 4: Managing Heart Failure in ATTR-CM

From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart failure care in ATTR-CM.

Todays Updates

Chiauranib Slows Platinum-Resistant Ovarian Cancer

The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.

Todays Updates

Chiauranib Slows Platinum-Resistant Ovarian Cancer

The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.

Latest News

Dr Yash Varma, a chief cardiology fellow, asks Dr Ileana Piña for her insights on when a patient with heart failure should be referred for advanced therapies.

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC.

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions.

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart failure care in ATTR-CM.

News All Time

Jehovah's Witnesses Transfusion Policy Now Allows Storage, Use of One's Own Blood

"I don't think it goes far enough, but it's a significant change," said one former member

Nobel-Winning Doctor Dies; 'Buffy' Star's Heart Defect; Cyberattack Delays Surgeries

Health news and commentary gathered by MedPage Today staff

Are We Missing Tumors When Using Antibiotics Alone for Appendicitis?

Study address key concern with nonoperative management of appendicitis

How Secretive Traditional Circumcision Rites Are Responsible for Dozens of Deaths

At least 48 boys and young men died during initiation ceremonies in South Africa

3 Medical Schools Under Investigation; 9 Sick in Outbreak; 5-Second Rule in the OR?

Health news and commentary gathered by MedPage Today staff

From the Operating Room to the Oscars

A Q&A with a physician consultant for the Academy Award-winning short, "All the Empty Rooms"

Trader Joe's Recall; 450 Hospitals May Close or Cut Services; 'Rib Remodeling' Trend

Health news and commentary gathered by MedPage Today staff

These Women Had Their Breasts Removed to Thwart Cancer. Then Came the Pain.

A look at "post-mastectomy pain syndrome"

Quiz Time: Why Was a Florida Doc Charged With Manslaughter?

You passed medical training, now see if you can pass our weekly quiz

Cosmetic Interventions Are Booming. Many Say Ethical Conversations Are Lagging.

— Demand has increased across all age demographics and ethnicities

Anti-TNF May Reduce Kidney Injury in Brain Death Donors

Researchers identify TNF driven injury pathways in brain death donors and test anti-TNF therapy to improve kidney graft quality before transplantation.

FDA Flags Shortage Of Neurosurgical Pads and Sponges

The U.S. Food and Drug Administration on Wednesday acknowledged ongoing supply disruptions of certain ⁠sterile pads, sponges and strips used in neurosurgery, warning the...

Ask the HF Expert: Managing Congestion

Chief fellow Yash Varma asks heart failure expert Ileana Piña for her tips and tricks in managing patients admitted with acute decompensated heart failure.

UK and US Set Path to Shared Medical Device Approvals

The MHRA and FDA have agreed to explore mutual recognition of medical device approvals, in a move that could cut delays for patients in both countries.

They Say Compassion Drains You. Science Disagrees

Research suggests it’s not compassion that wears doctors down but a different emotion — a distinction that may help them recharge more effectively.

You Haven’t Aged a Day: The Prognostic Value of Facial Aging

An AI study suggests that the rate of facial aging could be a biomarker for cancer mortality.

Recommended News For You

Hypnotherapy may offer real benefits for cancer patient care

Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

Fear of hair loss might cause some to reject cancer treatment

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

Herpes virus-based vaccine shows promise in targeting tumors without side effects

Improved end-of-life conversations for cancer patients are identified by a new study.

Recommended Articles For You

Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations 

Understanding Macrocytosis: Causes, Symptoms, and Treatment Options  

Unlocking the Potential of Cancer Antigen 19-9 for Early Detection 

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.

2.

Scientists develop scans that light up aggressive cancer tumors for better treatment

3.

Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.

4.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

5.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

1.

Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact

2.

Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management

3.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

4.

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease 

5.

Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part IV

2.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

5.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot